2月6日,阿斯利康在披露2024年度财报的同时,披露了关于涉嫌非法进口药品一事,其中明确:2025年1月,阿斯利康收到深圳海关出具的《移送审查起诉告知书》以及《鉴定意见通知书》,意见书显示阿斯利康涉嫌偷逃进口税款,金额达90万美元。2月6日,阿斯利康在披露2024年度财报的同时,披露了关于涉嫌非法进口药品一事,其中明确:2025年1月,阿斯利康收到深圳海关出具的《移送审查起诉告知书》以及《鉴定意见...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.